Astrana Health, Inc.
ASTH
$37.85
$0.471.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 258.44% | 117.43% | 73.12% | -39.99% | -62.84% |
| Total Other Revenue | 55.59% | 55.97% | 68.12% | 53.26% | 57.53% |
| Total Revenue | 56.69% | 56.39% | 68.17% | 51.97% | 54.81% |
| Cost of Revenue | 58.97% | 61.09% | 77.75% | 61.02% | 63.42% |
| Gross Profit | 39.88% | 25.85% | 14.27% | 5.43% | 11.49% |
| SG&A Expenses | 42.89% | 33.90% | 24.27% | 21.56% | 21.32% |
| Depreciation & Amortization | 83.22% | 63.82% | 51.70% | 34.03% | 59.99% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 58.13% | 58.97% | 72.44% | 56.88% | 59.35% |
| Operating Income | 18.19% | 0.10% | -14.39% | -25.09% | -12.10% |
| Income Before Tax | -25.15% | -50.99% | -63.89% | -45.86% | -29.67% |
| Income Tax Expenses | -30.97% | -49.72% | -21.34% | -16.04% | -15.78% |
| Earnings from Continuing Operations | -21.14% | -51.78% | -83.10% | -58.50% | -36.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 82.38% | 76.57% | -104.13% | -231.37% | -2,275.13% |
| Net Income | -13.64% | -47.89% | -84.73% | -63.08% | -43.92% |
| EBIT | 18.19% | 0.10% | -14.39% | -25.09% | -12.10% |
| EBITDA | 35.60% | 15.27% | 0.52% | -14.12% | -0.05% |
| EPS Basic | -14.71% | -49.20% | -85.75% | -64.34% | -45.29% |
| Normalized Basic EPS | -14.80% | -37.71% | -53.84% | -49.22% | -33.58% |
| EPS Diluted | -15.12% | -48.58% | -85.70% | -64.67% | -45.52% |
| Normalized Diluted EPS | -15.42% | -37.51% | -53.80% | -49.33% | -33.77% |
| Average Basic Shares Outstanding | 2.97% | 3.81% | 1.65% | 1.45% | 1.22% |
| Average Diluted Shares Outstanding | 3.58% | 3.72% | 1.42% | 1.45% | 1.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.34% | 170.11% | -0.32% | -0.73% | -0.84% |